‘The current skittish attitude towards China has driven down a lot of share prices’
Is healthcare a defensive play right now?
Bargains may be thin on the ground but there are good opportunities, says one CEO
Pictet Asset Management unveils Human thematic fund
Living longer brings with it a host of challenges
Healthcare stocks – race for a remedy
Hunt for treatments and vaccines puts spotlight on pharmaceutical companies
Data-driven medical devices to transform patients’ lives
Trends in the sector signal a more personalised, data-driven future
Gauging opportunities in healthcare innovation
‘The health market is in a state of upheaval,’ says Vigeo Eiris
LGIM unveils thematic ETFs focused on disruptive tech
Three new Ucits funds will focus on opportunities created by innovations in AI, healthcare and clean water
Biotech boom reinvigorates healthcare investment
Pharmaceuticals used to dominate healthcare sector, but focus has shifted towards innovation and disruption
The changing face of ESG in Asia
On the surface, Asia lags miles behind the west on key ESG issues – but the region is developing fast.
Biotech and pharma: a remedy for turbulent times?
In the decade since the financial crisis, pharmaceuticals, healthcare and bioscience-focused funds have significantly outperformed the MSCI World index.